baber/WOPTO huggingface dataset:
Patent NZ-610928-A (NZ)
Title: Cashew nut shell liquid with improved stability
Inventor: ITO SHINJI
IPC: C07C51/50
Filed: 2011-11-04
Abstract: Disclosed is a composition comprising a chelating agent and unheated cashew nut shell liquid or anacardic acid, wherein the chelating agent is selected from the group consisting of: i) an organic acid chelating agent or an organic acid salt chelating agent selected from the group consisting of: citric acid or a salt thereof excluding iron citrate salts; malic acid or a salt thereof; tartaric acid or a salt thereof; succinic acid or a salt thereof; propionic acid or a salt thereof; gluconic acid or a salt thereof; or glycolic acid or a salt thereof; or ii) a phosphoric acid chelating agent or a phosphate chelating agent selected from the group consisting of: orthophosphoric acid or a salt thereof; pyrophosphoric acid or a salt thereof; tripolyphosphoric acid or a salt thereof; tetrapolyphosphoric acid or a salt thereof; hexametaphosphoric acid or a salt thereof; or phytic acid or a salt thereof, or iii) an amino polycarboxylic acid chelating agent or an amino polycarboxylate chelating agent selected from the group consisting of: ethylenediamine tetraacetic acid or a salt thereof; ethylenediamine diacetic acid or a salt thereof; hydroxyethyl ethylenediamine tetraacetic acid or a salt thereof; diethylenetriamine pentaacetic acid or a salt thereof; nitrilotriacetic acid or a salt thereof; triethylenetetraamine hexaacetic acid or a salt thereof; dicarboxymethyl glutamine hexaacetic acid or a salt thereof; dicarboxymethyl glutamic acid tetrasodium salt; or dihydroxymethyl glycine.
Patent NZ-611198-A (NZ)
Title: Optical article comprising an antireflective coating with a low reflection both in the ultraviolet region and in the visible region
Inventor: CADO HERVÉ
IPC: G02C7/02
Filed: 2011-12-09
Abstract: Disclosed is an ophthalmic lens with a substrate with a front main face and a rear main face. The rear main face being coated with a multi layered antireflective coating comprising a stack of at least one layer having a refractive index higher than 1.6 and at least one layer having a refractive index lower than 1.5. The mean reflection factor on said rear face in the visible region is lower than or equal to 1.15% and the mean light reflection factor on said rear face in the visible region is lower than or equal to 1%. The mean reflection factor on said rear face between 280 nm and 380 nm, weighted by the function W() defined in the ISO 13666:1998 standard, is lower than 5% for an angle of incidence of 30° and for an angle of incidence of 45°. The multi layered antireflective coating comprises a number of layers higher than or equal to 3, preferably higher than or equal to 4, and lower than or equal to 7, preferably lower than or equal to 6, more preferably lower than or equal to 5. The multi layered antireflective coating does not comprise any layer with a thickness higher than or equal to 20 nm based on indium oxide. The antireflective coating outer layer is a silica-based layer.
Patent NZ-614096-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23K10/32
Filed: 2007-10-26
Abstract: 614096 Disclosed is a method of producing xylose, the method comprising: contacting a pretreated biomass feedstock with one or more cellulolytic enzymes to saccharify the feedstock, producing a mixture of sugars selected from the group consisting of glucose, xylose, arabinose, mannose, and galactose, fermenting glucose to produce an alcohol or organic acid and isolating the alcohol or organic acid as a first product, and isolating xylose as a second product, wherein the feedstock has been pre-treated by irradiating a lignocellulosic material with electron beam radiation at a dose of between 10 Mrad and 150 Mrad. Also disclosed is a sugar produced by the method.
Patent NZ-619899-A (NZ)
Title: Tissue targeted antigenic activation of the immune response to treat cancers
Inventor: GUNN HAROLD DAVID
IPC: A61P37/04
Filed: 2007-10-25
Abstract: Disclosed is the use of a non-infectious antigenic composition in the manufacture of a medicament for eliciting an immune response in a human patient suffering from cancer to treat the cancer situated in a specific organ or specific tissue of the human patient, or to prevent or ameliorate the metastasis of the cancer from a primary site in the human patient to a secondary site in the specific organ or specific tissue of the human patient, wherein: - the non-infectious antigenic composition comprises at least one attenuated bacteria of a species or strain that is pathogenic in the specific organ or tissue of the human patient; - the non-infectious antigenic composition does not produce infection in the specific organ or specific tissue of the human patient; and wherein, - the attenuated bacteria is an Escherichia coli and the specific organ or tissue is selected from the group consisting of: intra-abdominal lymph nodes; haematological tissues or organs; bone; brain; eye or orbit; small bowel; colon; rectum; anus; perineum; liver; gall bladder; biliary tract; pancreas; spleen; adrenal gland; kidney; ureter; bladder; peritoneum; prostate; testicle; ovary; adnexa; uterus; and vagina.
Patent NZ-631024-A (NZ)
Title: Therapies for hematologic malignancies
Inventor: GIESE NEILL
IPC: C07D473/34
Filed: 2009-11-13
Abstract: Disclosed is the use of (a) a compound of formula A which includes compounds such as (S)-5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one, wherein R is selected from the group consisting of H, halo, and alkyl; R’ is alkyl; or a pharmaceutically acceptable salt thereof; and optionally a pharmaceutically acceptable excipient, and (b) at least one additional therapeutic agent, wherein the at least one additional therapeutic agent is rituximab, ofatumumab, or a combination thereof; in the manufacture of a medicament for the treatment of a condition in a subject, wherein the condition is cancer; and wherein the subject is refractory to at least two standard or experimental chemotherapy treatments, resistant to chemotherapy treatment or in relapse after treatment with chemotherapy, and wherein the medicament is formulated for separate, sequential or simultaneous administration of (a) and (b).
Patent NZ-705425-A (NZ)
Title: Mixing drum drive apparatus
Inventor: TAKAHASHI YOSHIMITSU
IPC: F15B11/00
Filed: 2013-09-11
Abstract: This mixing drum drive apparatus is provided with: a hydraulic motor that rotatably drives a mixing drum; a hydraulic pump that is driven by the engine of a mixing truck, and supplies hydraulic fluid to the hydraulic motor; an auxiliary hydraulic pump that is driven by an electric motor, and supplies hydraulic fluid to the hydraulic motor; a pressure detector that detects the pressure of hydraulic fluid discharged from the auxiliary hydraulic pump; and a control valve that controls whether or not hydraulic fluid from the auxiliary hydraulic pump is supplied to the hydraulic motor. A controller opens the control valve if the pressure detected by the pressure detector is greater than or equal to a preset pressure when the control vale is closed and the mixing drum is being rotatably driven by the hydraulic motor driven by the hydraulic pump.
Patent NZ-707345-A (NZ)
Title: Maize cytoplasmic male sterility (cms) c-type restorer rf4 gene, molecular markers and their use
Inventor: REN RUIHUA
IPC: C12Q1/68
Filed: 2011-09-26
Abstract: This disclosure concerns high resolution mapping and candidate gene cloning of , a maize restorer of fertility gene that restores fertility to C-type cytoplasmic male sterility. The disclosure also relates to molecular markers that are tightly linked to, or reside within, the gene. In some embodiments, methods are provided whereby hybrid seeds may be produced from crosses of a male plant comprising nucleic acid molecular markers that are linked to or that reside within the gene and a female plant carrying C-type CMS.
Patent NZ-709732-A (NZ)
Title: Mass spectrometer with optimized magnetic shunt
Inventor: HOANG HUNG QUANG
IPC: H01J49/20
Filed: 2014-01-07
Abstract: The present invention relates to a mass spectrometer device comprising a source of ions, an electrostatic sector, a non-scanning magnetic sector arranged downstream of the electrostatic sector, for separating ions originating at the source of ions according to their mass-to-charge ratios, and detection means. A magnetic shunt is arranged in the drift space between the electrostatic sector and the magnetic sector. The proposed position of the magnetic shunt enhances the resolving power of the mass spectrometer device.
Patent NZ-712353-A (NZ)
Title: Methods for treating osteogenesis imperfecta
Inventor: LEE BRENDAN
IPC: A61P19/00
Filed: 2014-03-20
Abstract: The present invention provides methods for treating and improving the symptoms of osteogenesis imperfecta (OI) in a subject by administering to the subject a therapeutically effective amount of an antibody, or an antigen binding fragment, that binds to transforming growth factor beta (TGFβ)1, TGFβ2 or TGFβ3.
Patent NZ-712641-A (NZ)
Title: Reaction platform and method for making pollen based materials in combination with beeswax and uses thereof
Inventor: IONA ELIZABETH WEIR
IPC: A61Q19/00
Filed: 2014-08-12
Abstract: Disclosed is a topical skin composition, comprising a fermented pollen-based extract comprising one or more peptides, one or more fatty acids, and at least one dicaffeoylquinic acid isomer, together with one or more pharmaceutically or nutraceutically acceptable carriers, diluents and/or excipients. The topical skin formulation is suitable for treating skin conditions selected from the group comprising eczema, psoriasis, dermatitis, rosacea, acne, actinic keratosis (AK), moles, age spots, wrinkles, wounds, lacerations, scars, photodamage, herpes, corpus molluscum, and lupus.
Patent NZ-716900-A (NZ)
Title: A marine cleaning system
Inventor: DYHRBERG ROGER WAYNE RICHARD
IPC: B63B59/08
Filed: 2013-09-04
Abstract: A cleaning head is disclosed for cleaning a submerged surface. The cleaning head comprises a body portion and at least one cleaning member having at least one cleaning blade arranged to cause material on the submerged surface to separate from the submerged surface by scraping the material from the submerged surface when the cleaning head is disposed on the submerged surface during use and the cleaning member rotates relative to the submerged surface. The cleaning head also comprises at least one suction aperture through which material separated from the submerged surface by the at least one cleaning blade is drawn away from the cleaning head when a negative pressure is generated at the suction aperture, and a skirt portion extending around the cleaning member, the skirt portion performing a sealing function with the submerged surface when the cleaning head is disposed on the submerged surface during use. For each cleaning member, at least one of the suction apertures is disposed substantially centrally of the cleaning member and associated at least one cleaning blade. In addition, for each cleaning member, when the cleaning head is disposed on the submerged surface, the cleaning member rotates relative to the submerged surface, and the at least one suction aperture is connected in fluid communication with a device for generating negative pressure, material separated from the submerged surface by the at least one cleaning blade of the cleaning member is drawn away from the cleaning head through the suction aperture.
Patent NZ-732624-A (NZ)
Title: Biomolecule conjugates
Inventor: SCHWARTZ ERIC
IPC: A61K47/68
Filed: 2015-12-03
Abstract: The present invention relates to biomolecule conjugates which comprise a biomolecule wherein at least one non-natural amino acid (NNAA) is integral to the structure of the biomolecule and wherein the NNAA is a point of attachment of a linker to which a payload, particularly a cytotoxic agent, is attached. More specifically, this invention relates to conjugates of cell-binding agents and active release products comprising cytotoxic agents wherein the conjugates are produced by means of a cycloaddition reaction. Methods of production, pharmaceutical compositions and methods of use are provided.
Patent NZ-738258-A (NZ)
Title: High volume water electrolyzing system and method of using
Inventor: CRONCE KEITH L
IPC: B01D61/38
Filed: 2016-06-13
Abstract: An electrolyzing system for electrolyzing a brine solution of water and ions of an alkali salt to produce acidic electrolyzed water and alkaline electrolyzed water, the system comprising: a vessel for containing the brine solution comprising cations and anions and defining a brine bath; an electrolytic cartridge (figure) immersed in the brine bath; said electrolytic cartridge comprising a cathode cell and an anode cell; said cathode cell including a pair of cathode electrodes (C1,C2) connected to an electrical supply of direct current that negatively charges the cathode electrodes; a cathode electrode holder (20) supporting said cathode electrodes in coplanar laterally spaced side by side relation to each other in respective chambers sealed from each other; at least one cation permeable membrane (21) disposed on one side of each of said cathode electrodes defining a space between each cathode electrode and said at least one cation permeable membrane into which cations from the brine solution can enter through the at least one cation permeable membrane; said spaces between said each cathode electrode and said at least one cation permeable membrane being in communication with a fresh water supply inlet (55) at an inlet end of each space and in communication with a cleaning chemical outlet (56) at an outlet end of each space; said spaces between said each cathode electrode and said at least one cation permeable membrane being sealed off from each other and the brine solution such that the only path for the brine solution to enter the spaces is through said at least one cation permeable membrane; said anode cell including a pair of anode electrodes (A1, A2) connected to an electrical supply of direct current that positively charges the anode electrodes; an anode electrode holder (40) supporting said anode electrodes in coplanar laterally spaced side by side relation to each other in respective chambers sealed from each other; at least one anion permeable membrane (42) disposed on one side of said anode electrodes defining a space between each anode electrode and said at least one anion permeable membrane into which anions from the brine solution can enter through said at least one anion permeable membrane; said spaces between said each anode electrode and said at least one anion permeable membrane being in communication with a fresh water supply inlet at an inlet end of each space and in communication with a cleaning chemical outlet at an outlet end of each space; and said spaces between said each anode electrode and said at least one anion permeable membrane being sealed off from each other and the brine solution such that the only path for the brine solution to enter the spaces is through said at least one anion permeable membrane. The invention allows cells to be separated with a common separator plate that maintains the ion permeable membranes in parallel relation with the respective electrodes and which facilitates the communication of brine solution from a brine bath to both cells.
Patent NZ-753261-A (NZ)
Title: Methods and systems for ranking, filtering and patching detected vulnerabilities in a networked system
Inventor: HAMDI AMINE
IPC: G06F8/65
Filed: 2017-10-30
Abstract: Systems and methods for determining priority levels to process vulnerabilities associated with a networked computer system can include a data collection engine receiving a plurality of specification profiles, each defining one or more specification variables of the networked computer system or a respective asset. The data collection engine can receive, from a vulnerability scanner, vulnerability data indicative of a vulnerability associated with the networked computer system. A profiling engine can interrogate a computing device of the networked computer system, and receive one or more respective profiling parameters from that computing device. A ranking engine can compute a priority ranking value of the computing device based on the profile specification variables, the vulnerability data and the profiling parameters. The priority ranking value associated with the computing device can be indicative of a priority level, compared to other computing devices of the computer network, for patching a vulnerability affecting that computing device.
Patent NZ-761337-A (NZ)
Title: Environmentally friendly straw and manufacturing method thereof
Inventor: YEH JIA-CHENG
IPC: B21D1/06
Filed: 2020-02-03
Abstract: The invention teaches an environmentally friendly straw and its manufacturing method. The straw includes a tubular body having a through channel inside connecting two openings respectively at two ends of the tubular body, an outer layer surrounding the tubular body between the two openings formed by a leveling machine, an inner layer, as an inner wall of the tubular body, surrounding the channel formed by a honing machine. The straw is manufactured by leveling the tubular body, and honing the channel by a honing machine. As such, a smooth layer between the channel and the tubular body is achieved so that the straw is convenient to clean and use.
Patent PT-101019-A (PT)
Inventor: RIEDLL JUTTA
IPC: A61K47/04
Filed: 1992-10-29
Abstract: Described is a transdermal therapeutic system which is characterized in that it includes a crystallization inhibitor, and optionally also penetration enhancers, in an adhesive matrix containing the active substance.
Patent PT-104810-A (PT)
Title: M?quina e processo de extrac??o de bebidas por infus?o
Inventor: NABEIRO RUI MIGUEL
IPC: G03B21/00
Filed: 2009-11-06
Abstract: A M?QUINA DE EXTRAC??O DE BEBIDAS POR INFUS?O DE ACORDO COM A INVEN??O INCLUI UM DISPOSITIVO DE AMPLIA??O DE FOR?AS DO TIPO ALAVANCA ARTICULADA, APRESENTANDO PELO MENOS UM BRA?O MOTRIZ, PELO MENOS UM BRA?O DE AMPLIA??O E PELO MENOS UM BRA?O DE PRESS?O, E DIVERSOS BRA?OS INTERLIGADOS DE TAL FORMA ENTRE SI, POR MEIO DE LIGA??ES DE GIRO COMUNS, QUE PODEM RODAR EM VOLTA DE EIXOS DISPOSTOS DE UM MODO PREFERIDO PARALELOS ENTRE SI E A DIFERENTES N?VEIS, E QUE PERMITE AMPLIAR A FOR?A MOTRIZ EXERCIDA SOBRE UM RESPECTIVO PRIMEIRO BRA?O (BRA?O MOTRIZ E/ OU BRA?OS DE AMPLIA??O), DE MODO A EXERCER UMA FOR?A DE PRESS?O TAL, ATRAV?S DO PELO MENOS UM BRA?O DE PRESS?O, SOBRE A C?PSULA, QUE ESTA ? COLOCADA EM POSI??O E RETIDA DE FORMA FI?VEL EM POSI??O DURANTE O SEU ATRAVESSAMENTO POR UM FLUIDO QUENTE.
Patent PT-105524-A (PT)
Title: Transdutor de base óptica para medição de deslocamentos relativos em obras de arte de engenharia civil
Inventor: FIGUEIRAS JOAQUIM DE AZEVEDO
IPC: G01C5/00
Filed: 2011-02-11
Abstract: O PRESENTE INVENTO REPORTA-SE A UM TRANSDUTOR PARA MEDIÇÃO DE DESLOCAMENTOS RELATIVOS EM ESTRUTURAS DE ENGENHARIA CIVIL, TAIS COMO PONTES E VIADUTOS. COMO O PRÓPRIO NOME INDICA O APARELHO PERMITE MEDIR A VARIAÇÃO DE COMPRIMENTO ENTRE DOIS PONTOS DE UMA PEÇA, OU PEÇAS, POR ELE INSTRUMENTADAS. TAL INVENTO ENQUADRA-SE NO DOMÍNIO DA INSTRUMENTAÇÃO, PODENDO SER INTEGRADO EM SISTEMAS DE MONITORIZAÇÃO DA INTEGRIDADE ESTRUTURAL BASEADOS EM TECNOLOGIA ÓPTICA, DE CARÁCTER TEMPORÁRIO OU PERMANENTE. EVENTUALMENTE, PODERÁ INCLUIR TECNOLOGIA TRADICIONAL DE BASE ELÉCTRICA EM SUBSTITUIÇÃO, UMA VEZ QUE ESTA AINDA PREDOMINA NOS SISTEMAS DE MONITORIZAÇÃO QUE ACTUALMENTE SÃO IMPLEMENTADOS. ESTE TRANSDUTOR É CONSTITUÍDO POR UM CORPO EXTERIOR (1) E OUTRO INTERIOR CAPAZ DE MEDIR DESLOCAMENTOS RELATIVOS, POR INTERMÉDIO DE UMA CÉLULA DE CARGA ESPECÍFICA (2), MUNIDA DE ELEMENTOS EXTENSOMÉTRICOS (3). A ESTA ENCONTRA-SE ACOPLADA UMA MOLA HELICOIDAL (4) QUE PERMITE A TRANSDUÇÃO DO DESLOCAMENTO QUE LHE É EXTERIORMENTE IMPOSTO ATRAVÉS DA FORÇA NELA INSTALADA, MEDIDA PELA SUPRACITADA CÉLULA DE CARGA ATRAVÉS DOS SINAIS DOS SENSORES EXTENSOMÉTRICOS. ESTE TRANSDUTOR APRESENTA UM PRINCÍPIO DE FUNCIONAMENTO E UMA ARQUITECTURA INTERNA INOVADORES ASSOCIADOS A UMA CÉLULA DE CARGA DE ELEVADO DESEMPENHO E ESTABILIDADE. DESTA FORMA, OBTÉM-SE UM TRANSDUTOR DE DESLOCAMENTO DE NATUREZA ÓPTICA, COM COMPORTAMENTO LINEAR AO LONGO DO CAMPO DE MEDIDA, COM ELEVADA SENSIBILIDADE (0,04%FS) E ESTABILIDADE METROLÓGICA SOB CONDIÇÕES AMBIENTAIS EXTREMAS A LONGO PRAZO.
Patent PT-116489-A (PT)
Title: Plataforma para movimentação e descarga de varões de construção e respetivo processo de operação
Inventor: JORGE AUGUSTO GAGO GONÇALVES
IPC: B60P1/04
Filed: 2020-06-09
Abstract: PLATAFORMA (1) PARA MOVIMENTAÇÃO E DESCARGA DE VARÕES DE CONSTRUÇÃO EM VEÍCULOS DE CARGA (2), QUE COMPREENDE UM CORPO CENTRAL; DUAS BASES BASCULANTES (30) POSICIONADAS LONGITUDINALMENTE EM LADOS OPOSTOS DO CORPO CENTRAL, PARA DESLOCAMENTO BASCULAR RELATIVAMENTE AO CORPO CENTRAL; UM SUPORTE PARA SUPORTAR O CORPO CENTRAL E AS DUAS BASES BASCULANTES (30); EM QUE CADA UMA DAS BASES BASCULANTES (30) ESTÁ LIGADA AO SUPORTE POR UM ELEMENTO ELEVATÓRIO; EM QUE CADA UMA DAS ESTRUTURAS BASCULANTES COMPREENDE UMA PLURALIDADE DE FUEIROS (10, 20) ROTATIVAMENTE LIGADOS À RESPETIVA BASE, E EM QUE OS FUEIROS (10,20) ESTÃO POSICIONADOS LATERALMENTE NAS BASES BASCULANTES RODAREM PARA FORA E PARA BAIXO A PARTIR DA RESPETIVA BASE PARA PERMITIREM A DESCARGA DOS VARÕES QUANDO A RESPETIVA BASE (3) BASCULHE.
Patent RU-94015878-A (RU)
Inventor: GRITSENKO A G
IPC: A61H23/00
Filed: 1994-04-28
Abstract: FIELD: medicine. SUBSTANCE: to decrease the dizziness syndrome development frequency method involves the manual impact effect at the strength 10-12 kg/cm at the level of C2-C3, C5-D1. Effectiveness of method is evaluated to be 93%. EFFECT: enhanced effectiveness.
Patent RU-94021122-A (RU)
Inventor: STEKOL NIKOV L I
IPC: C07K1/107
Filed: 1994-06-09
Abstract: FIELD: biotechnology. SUBSTANCE: method involves dissolving human leukocyte interferon in water, addition of polymer and cross-linking agent to solution, mixture incubation at 20-25 C and the end product drying. Used polymer is hyaluronic acid and cross-linking agent is diethylenetriaminepentaacetic acid calcium-trisodium salt (pentacin) that were taken at amount 10-20 mg and 2-4 mg, respectively, per 1000000 U human leukocyte interferon. Incubation of mixture is carried out for 0.5-1 h. Obtained preparation shows the expressed prolonged action (24 h, not less). EFFECT: improved method of preparing.
Patent RU-94022238-A (RU)
Title: Homodimer of p40 interleukine-12
Inventor: MORIS KENT GEJTLI
IPC: A61P29/00
Filed: 1994-06-28
Abstract: FIELD: pharmacology, biochemistry. SUBSTANCE: desired homodimer have molecular weight 80 kDa. It comprises two subunits of p40 interleukine-12 being associated with each other preferably by at least disulfide bond. Proposed homodimer may be used as antagonist of receptor of interleucine-12. EFFECT: improved quality of desired product.
Patent RU-94022692-A (RU)
Inventor: NOVIKOV JA M
IPC: H02J13/00
Filed: 1994-06-10
Abstract: FIELD: electric power supply of industrial plants, namely predicting of electric loads of groups of electric receivers. SUBSTANCE: method comprises steps of performing before hand three-four measurements of mean electric loads over a predetermined time intervals for each type of electric power receiver at each technological mode; measuring a duration of each technological mode over three-four basic periods; according to data, had been received, calculating mean values and squared fluctuations of individual loads and duration values of technological modes and determining with an accuracy, necessary for a task, being decided, a number of additional measurements, being necessary for calculating designed characteristics of individual loads and duration of technological modes; then simulating with use of a computer according to a normal distribution law each electric power receiver and time mode of its operation; determining group load by mathematical simulation method. EFFECT: enhanced accuracy of the method, providing high reliability of power supply equipment operation.